SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-004449
Filing Date
2023-03-23
Accepted
2023-03-23 16:05:17
Documents
13
Period of Report
2023-03-17
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nhwk-20230317x8k.htm   iXBRL 8-K 49581
  Complete submission text file 0001558370-23-004449.txt   206263

Data Files

Seq Description Document Type Size
2 EX-101.SCH nhwk-20230317.xsd EX-101.SCH 4305
3 EX-101.DEF nhwk-20230317_def.xml EX-101.DEF 14026
4 EX-101.LAB nhwk-20230317_lab.xml EX-101.LAB 20095
5 EX-101.PRE nhwk-20230317_pre.xml EX-101.PRE 13690
7 EXTRACTED XBRL INSTANCE DOCUMENT nhwk-20230317x8k_htm.xml XML 7094
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
NightHawk Biosciences, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 23756174
SIC: 2834 Pharmaceutical Preparations